Amit Sachdev
EVP Chief Patient & Ext Af Off · VERTEX PHARMACEUTICALS INC / MA
- 2026
- Jul 23, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit Sachdev files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Reshma Kewalramani - $19.74M in VRTX purchases and sales in the last 12 months
- Carmen Bozic - $11.31M in VRTX purchases and sales in the last 12 months
- Charles F. Wagner Jr. - $6.38M in VRTX purchases and sales in the last 12 months
- Duncan McKechnie - $5.66M in VRTX purchases and sales in the last 12 months
- Ourania Tatsis - $4.38M in VRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amit Sachdev?
Amit Sachdev is a corporate insider, tracked as EVP Chief Patient & Ext Af Off of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Amit Sachdev submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Amit Sachdev been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($28.38M) across all tracked filings.
